Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Dec 6, 2022--
The "Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty; By Technology; By Disease Type; By End-Use; By Region; Segment Forecast, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The global rare disease genetic testing market size is expected to reach USD 2,414.90 million by 2030 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
Increasing technological advancements, including NGS and microarray, are prominent factors responsible for the market's growth. Also, the existence of Rare Diseases Clinical Research Network (RDCRN), an NIH-funded research network of 23 active research groups focused on the diagnosis & treatment of disorders, is anticipated to impact the industry positively. Furthermore, the decline in sequencing prices has shifted the attention to testing rare diseases, which has influenced the adoption of NGS, resulting in the market's growth.
Translational research and genomic technologies play a crucial role in accelerating the investigation and identification of new mutations, which aid in market expansion. Due to numerous translational research activities in this field, genetic testing in disease diagnostics is expected to rise rapidly throughout the projection period.
An increase in patient registry for rare diseases and development of new products to treat rare diseases are stimulating the growth of the market. The market is expected to grow as the number and quality of available registries continue to expand. So advanced data collection and interpretation technologies that can be used in clinical practices improve. An increasing number of patients undergoing disease testing, as well as increased government assistance, will fuel several new opportunities for market growth.
Rare Disease Genetic Testing Market Report Highlights
The publisher has segmented the rare disease genetic testing market report based on disease type, technology, specialty, end-use, and regions:
Rare Disease Genetic Testing, Disease Type Outlook (Revenue - USD Million, 2018 - 2030)
Rare Disease Genetic Testing, Technology Outlook (Revenue - USD Million, 2018 - 2030)
Rare Disease Genetic Testing, Specialty Outlook (Revenue - USD Million, 2018 - 2030)
Rare Disease Genetic Testing, End-Use Outlook (Revenue - USD Million, 2018 - 2030)
Rare Disease Genetic Testing, Regional Outlook (Revenue - USD Million, 2018 - 2030)
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Global Rare Disease Genetic Testing Market Insights
5. Global Rare Disease Genetic Testing Market, by Technology
6. Global Rare Disease Genetic Testing Market, by Specialty
7. Global Rare Disease Genetic Testing Market, by Disease Type
8. Global Rare Disease Genetic Testing Market, by End-use
9. Global Rare Disease Genetic Testing Market, by Geography
10. Competitive Landscape
11. Company Profiles
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/g3bh4a
View source version on businesswire.com:https://www.businesswire.com/news/home/20221206005839/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: GENETICS HEALTH MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 12/06/2022 10:51 AM/DISC: 12/06/2022 10:51 AM
http://www.businesswire.com/news/home/20221206005839/en